Academic Journal
Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause
| العنوان: | Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause |
|---|---|
| المؤلفون: | Gerard, Céline, Arnal, Jean-François, Jost, Maud, Douxfils, Jonathan, Lenfant, Françoise, Fontaine, Coralie, Houtman, René, Archer, David F, Reid, Robert L, Lobo, Rogerio A, Gaspard, Ulysse, Coelingh Bennink, Herjan J T, Creinin, Mitchell D, Foidart, Jean-Michel |
| المصدر: | Gerard , C , Arnal , J-F , Jost , M , Douxfils , J , Lenfant , F , Fontaine , C , Houtman , R , Archer , D F , Reid , R L , Lobo , R A , Gaspard , U , Coelingh Bennink , H J T , Creinin , M D & Foidart , J-M 2022 , ' Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause ' , Expert review of clinical pharmacology , vol. 15 , no. 2 , pp. 121-137 .... |
| سنة النشر: | 2022 |
| المجموعة: | Research Portal - University of Namur / Portail de la recherche de l'Université de Namur |
| مصطلحات موضوعية: | Combined oral contraception, contraception, E4, estetrol, estrogen, estrogen receptor, hemostasis, menopause, venous thrombosis |
| الوصف: | Introduction: Estrogens used in women’s healthcare have been associated with increased risks of venous thromboembolism (VTE) and breast cancer. Estetrol (E4), an estrogen produced by the human fetal liver, has recently been approved for the first time as a new estrogenic component of a novel combined oral contraceptive (E4/drospirenone [DRSP]) for over a decade. In phase 3 studies, E4/DRSP showed good contraceptive efficacy, a predictable bleeding pattern, and a favorable safety and tolerability profile. Areas covered: This narrative review discusses E4ʹs pharmacological characteristics, mode of action, and the results of preclinical and clinical studies for contraception, as well as for menopause and oncology. Expert opinion: Extensive studies have elucidated the properties of E4 that underlie its favorable safety profile. While classical estrogens (such as estradiol) exert their actions via both activation of nuclear and membrane estrogen receptor α (ERα), E4 presents a specific profile of ERα activation: E4 binds and activates nuclear ERα but does not induce the activation of membrane ERα signaling pathways in specific tissues. E4 has a small effect on normal breast tissue proliferation and minimally affects hepatic parameters. This distinct profile of ERα activation, uncoupling nuclear and membrane activation, is unique. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| DOI: | 10.1080/17512433.2022.2054413 |
| الاتاحة: | https://researchportal.unamur.be/en/publications/f34bd4d2-3da9-48dd-9cb1-68733cec6b4e https://doi.org/10.1080/17512433.2022.2054413 https://pure.unamur.be/ws/files/63123362/9679_2022_Ge_rard.pdf http://www.scopus.com/inward/record.url?scp=85127351500&partnerID=8YFLogxK |
| Rights: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.CF5BC05A |
| قاعدة البيانات: | BASE |
| DOI: | 10.1080/17512433.2022.2054413 |
|---|